Abstract
Ewing sarcoma is an aggressive pediatric cancer of enigmatic cellular origins typically resulting from a single translocation event t (11; 22) (q24; q12). The resulting fusion gene, EWSR1-FLI1, is toxic or unstable in most primary tissues. Consequently, attempts to model Ewing sarcomagenesis have proven unsuccessful thus far, highlighting the need to identify the cellular features which permit stable EWSR1-FLI1 expression. By re-analyzing publicly available RNA-Sequencing data with manifold learning techniques, we uncovered a group of Ewing-like tissues belonging to a developmental trajectory between pluripotent, neuroectodermal, and mesodermal cell states. Furthermore, we demonstrated that EWSR1-FLI1 expression levels control the activation of these developmental trajectories within Ewing sarcoma cells. Subsequent analysis and experimental validation demonstrated that the capability to resolve R-loops and mitigate replication stress are probable prerequisites for stable EWSR1-FLI1 expression in primary tissues. Taken together, our results demonstrate how EWSR1-FLI1 hijacks developmental gene programs and advances our understanding of Ewing sarcomagenesis.
Funding Information
  • National Institutes of Health (1R01CA152063, 1R01CA241554, TL1TR002647, P30CA054174, T32GM113896 / STXMSTP, 1S10OD021805-01)
  • Cancer Prevention and Research Institute of Texas (RP150445, RP101491, RP160732)
  • National Center for Advancing Translational Sciences (TL1TR002647)
  • National Cancer Institute (T32CA148724)
  • AACR-AstraZeneca (18-40-12-GORT)
  • Congressionally Directed Medical Research Programs (W81XWH-19-1-0180)
  • National Institute on Aging (F30 AG057213)

This publication has 44 references indexed in Scilit: